RXST - RxSight Inc
25.84
0.620 2.399%
Share volume: 437,270
Last Updated: 03-14-2025
Medical Equipment/Ophthalmic Goods:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$25.22
0.62
0.02%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-06-2024 | 08-05-2024 | 11-07-2024 | 02-25-2025 | |
Total revenue | 29.512 M | 34.887 M | 35.314 M | 40.214 M | |
Cost of revenue | 8.827 M | 10.637 M | 10.094 M | 11.426 M | |
Gross profit | 20.685 M | 24.250 M | 25.220 M | 28.788 M | |
17.23% | 4.00% | 14.15% | |||
Operating expenses | 31.355 M | 32.583 M | 34.446 M | 37.417 M | |
Selling general and admin | 23.324 M | 24.292 M | 25.608 M | 28.210 M | |
Research and development | 8.031 M | 8.291 M | 8.838 M | 9.207 M | |
Total expenses | 31.355 M | 32.583 M | 34.446 M | 37.417 M | |
3.92% | 5.72% | 8.63% | |||
Operating income | -10.670 M | -8.333 M | -9.226 M | -8.629 M | |
Ebit | -10.670 M | -8.333 M | -9.226 M | -8.629 M | |
Pretax income | -9.091 M | -6.063 M | -6.325 M | -5.926 M | |
-33.31% | 4.32% | -6.31% | |||
Income tax | 9.000 K | 16.000 K | 13.000 K | 12.000 K | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -9.100 M | -6.079 M | -6.338 M | -5.938 M | |
33.20% | -4.26% | 6.31% |